Discussion  by unknown
Myers et al Congenital Heart Disease
C
H
Dalong the curve of normal somatic tricuspid annular growth
in children with congenital tricuspid regurgitation (unpub-
lished data, presented at the Society of Thoracic Surgeons
2010 Annual Meeting, Poster P48). It is thus possible that
the relatively low rates of reoperation and elevated trans-
valvular gradients were favorably biased by the use of this
biodegradable ring. Thus, caution is advised if applying
the results of the present study to other annuloplasty devices
or techniques.
The present studywas limited by the relatively small sam-
ple size, retrospective, nonrandomized design, and midterm
follow-up. Both groups were matched for the presence of
leaflet restricted motion or tethering, age, valve treated,
and etiology of valve disease and no significant differences
in the preoperative patient characteristics were found. How-
ever, the control group was not exactly similar because the
standard repair techniques were sufficient to relieve leaflet
restriction or tethering without resorting to our additional
suspension stitch in the control group. Furthermore, the sam-
ple size did not allow for propensity score analysis. The use
of the suspension stitch was determined by subjective crite-
ria at water testing of the mitral or tricuspid valve when the
standard techniques were not sufficient to decrease the de-
gree of residual insufficiency. Thus, a selection bias could
not be ruled out. The multivariate models used for Cox pro-
portional hazards modeling were limited by the number of
events. Only 5 events occurred for 8 degrees of freedom in
the models using reoperation as an outcome and 7 events
in the models using a high transvalvular gradient as an out-
come. However, 5 to 10 times more events than degrees of
freedom are usually recommended. Finally, follow-up echo-
cardiographic data were mostly interpreted and analyzed by
the referring cardiologist in the patients’ country of origin.
This introduced the risk of estimator bias, because the echo-
cardiographic images could not be interpreted by an inde-
pendent echocardiography laboratory unaware of the
surgery and clinical outcome. Furthermore, more detailed
data, such as the right ventricular dimensions, or quantitative
methods of grading regurgitation, such as the actual width of
the vena contracta or proximal isovelocity surface area,
could not be obtained in a large proportion of patients.
CONCLUSIONS
The suspension technique described is simple and safe. It
moves the retracted or tethered leaflet up to the coaptation
plane, thus creating a larger coaptation area that can elimi-
nate regurgitation. In our experience of 40 children, ade-
quate leaflet coaptation was achieved and allowed the
avoidance of valve replacement. This result was maintained
in all but 3 children during a median follow-up of 37 months
and extending up to 7 years. No technical failures of the
stitch and no leaflet abrasion occurred during follow-up.
Also, stenosis did not develop. These results were compara-
ble to the results in the control group.The Journal of Thoracic and CarReferences
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Dr Luca Vricella (Baltimore, Md). I would like to thank the or-
ganizing committee for the privilege of starting the discussion on
this very interesting series of patients with mitral valve regurgita-
tion and Dr Myers for kindly providing me in advance with thediovascular Surgery c Volume 140, Number 5 1115
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Dmanuscript and video for this presentation. Let me congratulate the
group in Geneva and Dr Kalangos, in particular, on their outstand-
ing results with mitral valve repair in children. I have a few com-
ments and 3 questions.
This particular technique is really a modified Alfieri suture. The
difference is that the posterior leaflet is displaced superiorly and
anteriorly rather than creating a double orifice valve. I can see
how in patients with isolated posterior leaflet restriction, which
was the case, this would have minimal impact on creating stenosis
and also only create diastolic stress on the suture. I assume that the
suspension is performed in all cases after placement of an annulo-
plasty ring and immediately after saline testing rather than after
a first attempt at weaning from cardiopulmonary bypass. So you
are actually testing the valve with a subjective test, and then you
come off bypass after putting the stitch, thereby acting on objective
data that documents regurgitation. So it might be the annuloplasty
band that corrects the regurgitation, rather than your suture, you
just do not know.
So, my first question is, in these cases, you used a particular re-
absorbable or partial ring with an average size of 26 mm in a group
of patients with a mean age of 11 years. Do you think that a similar
result could have been achieved by slightly undersizing the annu-
loplasty? In other words, how significant was the contribution of
type I regurgitation, because you brought the diameters down to
26 mm, which is a size very close to an adult-size mitral valve?
Also, in the manuscript, as you said, these patients all had type I
and type III abnormalities.
Dr Cikirikcioglu. Thank you very much for your comments.
The mean size of the biodegradable ring in this series was 26.
However, when we looked at all the patients, there are some
smaller sizes, used in younger children, which are not available
in traditional rings. However, the use of the appropriate biodegrad-
able ring size allows us to keep the transmitral gradient stable dur-
ing the follow-up period. In our opinion, it is not really the best
option to ensure a better coaptation surface only by using under-
sized valvuloplasty in these patients in whom the posterior leaflet
is severely retracted and tethered.
Dr Vricella. But you actually did do that in 40 patients in this
series, right, you just did an annuloplasty ring?
Dr Cikirikcioglu. Yes, with associated repair techniques.
Dr Vricella. The second question is: At the time of the oper-
ation in the suspension stitch group, you performed secondary
and primary chordal shortening and triangular leaflet, resection
in a substantial number of patients. These techniques are also of-
ten used in patients who have type II motion abnormality. So the
question here is you also performed leaflet indentation closure
and commissuroplasty in 43% and 15% of patients in this group.
So, these can actually pull tissue away from the anterior leaflet.
Is it possible that in a fair amount of patients in this group,
restriction was actually worsened by aggressive use of these
techniques?
Dr Cikirikcioglu. Secondary and primary chordal transfer was
used to correct the pseudoprolapse of the anterior leaflet secondary
to the posterior leaflet retraction.1116 The Journal of Thoracic and Cardiovascular SurDr Vricella. I can just see how if you actually start plicating or
doing triangular resections, you can actually pull the 2 leaflets
away from their coaptation area, so it was a concern of mine.
The last question I had was: What were the findings at the time
of the reoperation in the 3 patients with late failure in suspension
group? The time to reintervention in this particular group was sig-
nificantly shorter, it was 8 versus 36 months.
Dr Cikirikcioglu. It was our will to push the limits too much to
repair these more severely affected rheumatic mitral valves in the
suspension stitch group compared with the control group. I think
the reoperations were not related to the techniques but to the sever-
ity of the rheumatic disorder.
Dr Vricella.Well, congratulations on your presentation. I think
your excellent results underscore the importance of trying at all
costs to repair valves in children rather than to replace them.
Dr Marshall Jacobs (Cleveland, Ohio). It is a very, very nice
presentation of your technique and a nice analysis.
Echoing something that was in the primary discussant’s com-
ments, it appeared from your data that the aortic crossclamp
time was virtually the same for the suspension stitch group and
the other group, which means it did not take you long to do it.
Also, I assume, based on your enthusiasm for the procedure, that
your threshold for doing it is probably lowish, because you see
very little downside.
On the other hand, like the previous discussant, I find it very sur-
prising that you reported no cases in which you did a repair, came
off cardiopulmonary bypass, found residual regurgitation that you
thought might be attributed to immobility or tethering, and went
back and solved that problem by placement of a tethering stitch.
Have you had that experience? Were there any such cases that per-
haps were not in this series?
Dr Cikirikcioglu. Based on our repair strategy, in occasional
cases, we went back to solve the residual regurgitation. Also, as
you noticed in the video, if you have residual regurgitation after
repair, it is not logical to leave this residual regurgitation.
Our strategy is, first to obtain the best coaptation surface with-
out any residual leak and then to see the dynamic final result on the
transesophageal echocardiogram.
DrKhanh Nguyen (New York, NY). I really enjoyed the presen-
tation. I noticed that you only spend 1% of the time trying to do
artificial chord placement. I am wondering whether you can re-
lease the tethered leaflet, lift it by just transecting the chord that
is holding it down, and use Gore-Tex chords. Also, I would think
that that would release the restriction significantly. Have you tried
that technique?
Dr Cikirikcioglu. It is another option you can use. I mean, this
technique can be useful also, I agree. But, in my opinion, our sus-
pension technique is fast and reproducible and safe, and our mid-
term results are good. Usually these cases are coming to surgery at
late stage with bad ventricular function. Thanks to the suspension
technique, we are able to decrease the crossclamping time. For this
reason, I agree with you, resection of retracted primary chordae
and their replacement with an artificial chordae can also be used
as an alternative technique, but we did not do that.gery c November 2010
